Michael B. Smith

Internal Medicine
725 Colonel Glenn Hwy
Dayton, OH 45435

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer.

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer.

Journal: Investigational new drugs
Published: July 22, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026